In addition, these primary NONO-TFE3 targeted genes identified in UOK109 cells are highly expressed not only in patients bearing NONO-TFE3 fusions but also across various fusion types in tRCC patients with various MiT oncofusion events (Supplementary Fig. 3e)41. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.